Cite

    D. Truong et al.. “Effect of baseline dyskinesia on safety and efficacy of istradefylline, an A2A receptor antagonist, in Parkinson's disease: 8-study pooled analysis.” Parkinsonism & related disorders, vol. 79, n.d., pp. e55–e56. http://access.bl.uk/ark:/81055/vdc_100118543085.0x00001e